Rapamycin: a new hope for delaying menopause?
NCT ID NCT05836025
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tests whether a low dose of rapamycin, a drug that affects aging pathways, can slow down ovarian aging in women aged 35 to 45 who are in early menopause transition. Researchers will measure hormone levels and egg supply over time. The goal is to see if the drug can extend fertility and delay menopause.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIMENOPAUSAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.